27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Gainers
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- Reviva Pharmaceuticals (NASDAQ:RVPH) stock moved upwards by 72.5% to $2.64 during Monday's regular session. Trading volume for this security as of 13:30 EST is 19.2 million, which is 3524.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $47.8 million.
- Sonendo (NYSE:SONX) shares increased by 30.77% to $1.2. The current volume of 635.2K shares is 591.4% of Sonendo's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $31.9 million.
- BioVie (NASDAQ:BIVI) shares moved upwards by 19.43% to $3.2. BioVie's stock is trading at a volume of 140.3K shares as of 13:30 EST. This is 247.6% of its average full-day volume over the last 100 days. The company's market cap stands at $79.6 million.
- PolarityTE (NASDAQ:PTE) stock rose 17.54% to $1.12. Trading volume for this security as of 13:30 EST is 825.2K, which is 395.2% of its average full-day volume over the last 100 days. The company's market cap stands at $6.3 million.
- Minerva Neurosciences (NASDAQ:NERV) stock rose 14.52% to $11.83. The current volume of 53.5 million shares is 1502.1% of Minerva Neurosciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $63.1 million.
- Plus Therapeutics (NASDAQ:PSTV) shares moved upwards by 14.52% to $1.0. Trading volume for Plus Therapeutics's stock is 5.0 million as of 13:30 EST. This is 139.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $23.1 million.
Losers
- Absci (NASDAQ:ABSI) stock declined by 14.7% to $3.56 during Monday's regular session. As of 13:30 EST, this security is trading at a volume of 229.5K shares, making up 36.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $330.9 million.
- Akoya Biosciences (NASDAQ:AKYA) shares decreased by 14.15% to $11.96. The company's market cap stands at $453.1 million.
- Baudax Bio (NASDAQ:BXRX) shares decreased by 13.27% to $0.56. Trading volume for this security as of 13:30 EST is 1.5 million, which is 274.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.4 million.
- Aytu BioPharma (NASDAQ:AYTU) shares fell 13.11% to $0.23. Trading volume for Aytu BioPharma's stock is 4.1 million as of 13:30 EST. This is 388.6% of its average full-day volume over the last 100 days. The company's market cap stands at $14.4 million.
- Humanigen (NASDAQ:HGEN) shares declined by 12.41% to $0.25. Humanigen's stock is trading at a volume of 10.0 million shares as of 13:30 EST. This is 118.3% of its average full-day volume over the last 100 days. The company's market cap stands at $25.4 million.
- Nymox Pharmaceutical (NASDAQ:NYMX) shares fell 12.05% to $0.4. Trading volume for Nymox Pharmaceutical's stock is 58.6K as of 13:30 EST. This is 15.6% of its average full-day volume over the last 100 days. The company's market cap stands at $36.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.